Efficacy in patients with EGFR-positive non-small-cell lung cancer treated with dacomitinib who had skin adverse events: post hoc analyses from ARCHER 1050. - Pu X; Li J; Zhang B; Zhang J; K Mok TS; Nakagawa K; Rosell R; Cheng Y; Zhou X; Miglorino MR; Niho S; Lee KH; et al. (Future oncology (London, England), 2024)